Search - tctmd.com

Displaying 181 - 200 of 232

Sort: Relevancy | Date

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

New PCI Performance Measures Issued to Improve Quality of Care

January 06, 2014

News Daily News

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

October 16, 2013

News Daily News

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

L.A. McKeown

October 15, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Daily News

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

Yael L. Maxwell

May 13, 2013

News Daily News

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

Caitlin E. Cox

May 13, 2013

News Daily News

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Yael L. Maxwell

April 26, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

Advertisement

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

New PCI Performance Measures Issued to Improve Quality of Care

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content